DermTopic: Psoriasis

Floodwaters and Climate Change Increase Risks for Dermatolog…

As more frequent and intense flooding disasters have occurred in conjunction with progressively rising temperatures, bot…

FDA Approves Janssen's Tremfya One-Press

The FDA has approved Tremfya® One-Press, a single-dose, patient-controlled injector for adults with moderate-to…

Perspective: Mental Health is Skin Health

Our skin is remarkable. It is not only the largest organ in our body -- accounting for 16 percent of our total body …

Helen Taylor

Long-term Management Strategies for AD, Melasma, and More

Protecting the Barrier in Adult Atopic Dermatitis “I still think it’s so important to remember topica…

Biologics in Psoriasis: The Next Generation

Alefacept (Amevive) and efalizumab (Raptiva) initiated the biologic era in the treatment of psoriasis. Low efficacy …

Jerry Bagel, MD

Currents: The Skin After...

After Psoriasis: Treatment Effects on Comorbidities Treating psoriasis with biologic drugs can reduce the early plaqu…

Recent Developments

Jeuveau from Evolus Now FDA Cleared for Aesthetic Injection The FDA has approved Jeuveau (prabotulinumtoxinA-xvfs) fr…

Two New Psoriasis Guidelines Address Comorbidities, Biologic…

The American Academy of Dermatology and the National Psoriasis Foundation have released two new guidelines outlining bes…